肝积颗粒合介入治疗原发性肝癌的临床观察

目的：观察肝积颗粒合介入治疗原发性肝癌气虚血瘀证的临床疗效。方法：将符合研究条件的患者随机分为治疗组（30例）和对照组（30例），分别采用肝积颗粒保介入治疗和单纯介入治疗，观察两组的近期临床疗效、远期生存时间以及T细胞亚群、AFP值的变化情况。结果：治疗组瘤体缓解率为20．00％、稳定率为90．00％，对照组分别为16．67％、63．33％，其中，瘤体稳定率两组差异有显著性（P＜0．05），治疗组在减轻临床症状，延长生存时间、升高CD3、CD4值等方面优于对照组（P＜0．05），两组AFP值变化比较，差异无显著性。结论：肝积颗粒联合介入治疗原发性肝癌气虚血瘀证，可提高临床疗效，改善临床症状，增强机体免疫功能，延长生存期。     

华蟾素配伍丝裂霉素体外抑瘤作用

目的：从体外药敏实验的角度观察华蟾素注射液配伍丝裂霉素对不同肝癌细胞抑瘤效果和对正常肝细胞的毒性反应。方法：通过四甲基偶氮唑盐比色法观察低浓度华蟾素注射液、丝裂霉素及两配伍使用时对人肝癌细胞系SMMC-721、BEL—7402细胞及正常肝细胞系L-02细胞的生长抑制作用。结果：对人肝癌细胞的生长抑制作用，华蟾素及丝裂霉素两配伍使用较两单独使用显增强；丝裂霉素对正常肝细胞具有一定生长抑制作用，而华蟾素注射液则无此作用，与单独使用丝裂霉素比较，两的配伍使用对正常肝细胞的生长抑制作用未见明显增加。结论：华蟾素和丝裂霉素配伍使用可显提高对人肝癌细胞的杀伤作用，同时未增加对正常肝细胞的生长抑制作用，提示华蟾素和丝裂霉素配伍使用在肝癌治疗中具有很好的临床应用前景。     

人肺癌中TNF-α基因多态性分布的意义及其对细胞凋亡的影响

目的:观察TNF-α基因启动子区-308位核苷酸多态性基因型在肺癌和对照人群中的分布,以及这种多态性对该基因表达和细胞凋亡的影响。方法:PER-RFLP分析112例肺癌和99例正常人的TNF-α基因启动子区-308位核苷酸多态性,TNF-α-308*G等位基因记做TNF-α1,TNF-α-308*A等位基因记做TNF- α2。免疫组织化学方法检测肺癌组织中TNF-α的表达,比较不同基因型肺癌病例的标本之间TNF-α基因表达的差异性。TUNEL法检测肺癌组织中细胞凋亡,并对比分析TNF-α-308位核苷酸多态性及其对肺癌组织中TNF -α表达和不同类型细胞凋亡的影响。结果:肺癌组与对照组的基因型分布为TNF-α1/1(52．7％、46．5％)。 TNF-α1/2(35．7％、48．5％),TNF-α2／2(11．6％、5．1％);等位基因频率为TNF-α1(70．5％、70．7％),TNF- α2(29．5％、29．3％),组间没有显著性差异,P>0．05。两种基因型个体在TNF-α基因表达上,TNF-α2/2基因型个体高于TNF-α1／1基因型的个体,两者差异显著,P<0．01。TNF-α表达的高低与癌细胞凋亡有比较明确的关系,TNF-α表达高的病例,肺癌细胞凋亡也多,与表达低的病例之间有明显差异,P<0．01。TNF-α表达的高低与间质细胞凋亡之间没有明确的关系。间质细胞平均凋亡指数在高、低分化的肺癌中分别为3．4±0．4和 3．1±0．5,组间没有显著性差异,P>0．015;癌细胞的平均凋亡指数在高、低分化的肺癌中分别为2．4±0．3和 1．7±0．4,两组间有显著性差异,P<0．05,,结论:TNF-α-308位核苷酸的多态性基因型在肺癌和正常人中的分布之间没有明显差别,这种多态性可能不是肺癌易感的遗传因素。但这种多态性与该基因的表达有关。TNF-α高表达肺癌细胞凋亡较多,间质细胞凋亡与TNF-α表达的高低变化之间没有明确的关系。在高分化的肺癌中, TNF-α表达较高,癌细胞凋亡也多,TNF-α-308位核苷酸的多态性可能与了肺癌的分化有关。     

Shining a light on the grey zones of gender construction: breast surgery in France and Italy

This article analyses the areas of overlap between cosmetic surgery and reconstructive surgery, using the examples of both female and male breast surgery, and shows that these areas of overlap are sites of the construction of gendered bodies. The data are drawn from two pieces of research: the first based on 17 in-depth interviews with Italian cosmetic surgeons and the second based on 99 interviews with breast cancer patients and medical oncological professionals conducted in France and Italy. The primary data are supplemented by an analysis of the medical literature. ‘Too small’ female breasts (micromastia) and male gynecomastia (male fatty breast tissue) are pathologised by the surgeons and the medical literature, and a surgical intervention is presented as a way to heal this pathology. The pathologisation of healthy breasts goes along with the aestheticisation of oncological breast surgery. The interventions performed during a post-mastectomy breast reconstruction are guided by normative ideas of how a female body should be. The gender norms inscribed in this surgery practice can however be contested by patients: they can ask for a breast reconstruction while refusing all forms of ‘enhancement’.     

‘Flat and fabulous’: women’s breast reconstruction refusals post-mastectomy and the negotiation of normative femininity

The ‘pinkification’ of breast cancer culture in recent years conflates women’s empowerment with the celebration of hyperfemininity. Consistent with this trend, reconstructive surgery post-mastectomy is increasingly normalised: restoring the breasts is to restore ‘lost’ femininity. Contextualised within the pressures of this normalisation, our article explores how women who decide against breast reconstruction negotiate their non-normative ‘flat’ bodies. We examine women’s posts in a breast cancer forum about their refusals of breast reconstruction. Using thematic and feminist post-structuralist analyses, we suggest that although health and body acceptance discourses enable resistance to embodied femininity norms, pressures to conform permeate practices related to appearance. Clothes and prosthetic breasts enabled forum participants to pass as ‘healthy’, ‘whole’, and ‘recovered’. The study’s findings emphasise the limitations to agency and resistance that emanate from the ways constraining gender discourses infiltrate every aspect of a woman’s life. In line with a critical awareness approach to breast cancer education, we discuss the possibilities of resistance afforded by the safe spaces of online communities.     

马立克病病毒致瘤相关基因的研究进展

从meq基因、pp38复合体、HSV ICP4的同源体、L开放阅读框(L ORF)、位于BamHⅠ-H片段的基因和病毒类白细胞介素-8(vIL-8)等几个方面论述了马立克病病毒感染期间参与肿瘤形成的相关基因的生物学活性。     

葛根和黄芩乙醇提取物体外抗乳腺癌实验研究

目的:考察葛根和黄芩乙醇提取物体外抗乳腺癌细胞增殖活性。方法:葛根及黄芩200,400,700,950 m l/L乙醇提取物作用于人乳腺癌MCF-7(ER )和MDA-MB-231(ER-)细胞,MTT法检测对细胞增殖的影响。结果:葛根950 m l/L乙醇提取物在100~800μg/m l剂量均能显著抑制人乳腺癌细胞增殖,700 m l/L乙醇提取物也显示了一定的抗肿瘤细胞生长活性,200,400 m l/L乙醇提取物未见明显的抑制乳腺癌细胞增殖作用;黄芩950,700 m l/L乙醇提取物在50~400μg/m l剂量均能显著抑制人乳腺癌细胞增殖,400 m l/L乙醇提取物也显示了一定的抗肿瘤细胞生长活性,而200 m l/L乙醇提取物未见明显的抑制肿瘤细胞增殖作用。结论:葛根和黄芩乙醇提取物有一定的抑制乳腺癌细胞增殖作用。     

Fingerprint Change: Not Visible,But Tangible

Hand–foot syndrome, a chemotherapy‐induced cutaneous toxicity, can cause an alteration in fingerprints causing a setback for cancer patients due to the occurrence of false rejections. A colon cancer patient was fingerprinted after not having been able to use fingerprint recognition devices after 6 months of adjuvant chemotherapy. The fingerprint images were digitally processed to improve fingerprint definition without altering the papillary design. No evidence of skin toxicity was present. Two months later, the situation returned to normal. The fingerprint evaluation conducted on 15 identification points highlighted the quantitative and qualitative fingerprint alteration details detected after the end of chemotherapy and 2 months later. Fingerprint alteration during chemotherapy has been reported, but to our knowledge, this particular case is the first ever reported without evident clinical signs. Alternative fingerprint identification methods as well as improved biometric identification systems are needed in case of unexpected situations.     

死亡人体胸肌组织中rRNA亚基的稳定性评价

目的观察尸体胸大肌组织中rRNA各亚基表达水平的死后稳定性,探讨其在死亡时间推断中应用的价值。方法选取6例（3例成人、3例婴幼儿）外界温、湿度环境基本一致、死亡时间基本一致（24h以内）的个体,提取左侧胸大肌组织,在PBS缓冲液中低温冻存,分别在尸检即刻、2、3、4、5、6、7、8、9、10d提取微量组织保存于RNA固定液中,通过实时荧光定量RT-PCR技术检测rRNA 5srRNA、5.8srRNA、18srRNA、28srRNA亚基的表达水平。并分析年龄、死因对rRNA亚基表达水平的影响。结果死后各时间点rRNA各亚基的表达随死后经过时间延长无显著性降解,Ct值变化与死后经过时间无相关性（P值均大于0.05）,其中5s rRNA在18.503±2.655~20.937±2.340之间,5.8s rRNA在17.687±3.011~20.617±2.204之间,18s rRNA在16.457±3.920~22.330±2.571之间,28s rRNA在15.077±6.051~22.207±2.685之间。结论人体胸肌组织中rRNA各亚基稳定性好,其各亚基的表达量与死因、年龄无关,适于作为晚期死亡的推断的内参基因。     

A Clinical Trials Recruitment Education Program for Immigrant Chinese Americans

Abstract

This study was designed to develop and evaluate a community-based education program to facilitate enrollment of immigrant Chinese into clinical cancer screening trials. The program included workshops with culturally tailored health education materials. It was piloted to recruit persons into an ongoing lung cancer screening trial from a senior citizen center in Manhattan's Chinatown and compared with a control program at a second senior center. Survey results from a convenience sample of seniors showed that the workshop raised awareness about cancer screening and clinical trials. However, it did not change attitudes towards cancer screening. The results highlighted prior focus group findings in which factors influencing participation in cancer screening and clinical trials are similar. Important facilitative factors include doctor recommendation, friend/family recommendation, the belief that early detection could “save lives,” no cost, and having an-interpreter.